Merkel cell polyomavirus small T antigen mediates microtubule destabilization to promote cell motility and migration

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 35-47

  Knight, Laura M ^a   Stakaityte, Gabriele ^a   Wood, Jennifer J ^a   Abdul Sada, Hussein ^a   Griffiths, David A ^a   Howell, Gareth J ^a   Wheat, Rachel ^b   Blair, G Eric ^a   Steven, Neil M ^b   Macdonald, Andrew ^a   Blackbourn, David J ^c   Whitehouse, Adrian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PP4C; STATHMIN; UNCLASSIFIED DRUG; VIRUS SMALL T ANTIGEN; PROTEIN PHOSPHATASE 4; PROTEOME; STMN1 PROTEIN, HUMAN; VIRUS T ANTIGEN;

ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE STABILIZATION; MERKEL CELL POLYOMAVIRUS; MICROTUBULE; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; CELL LINE; CELL MOTION; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY;

POLYOMAVIRUS;

ANTIGENS, VIRAL, TUMOR; CELL LINE; CELL MOVEMENT; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; MERKEL CELL POLYOMAVIRUS; MICROTUBULES; PHOSPHOPROTEIN PHOSPHATASES; PROTEOME; STATHMIN;

EID: 84919444215     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02317-14     Document Type: Article

References (77)

1. Becker JC, Schrama D, Houben R. 2009. Merkel cell carcinoma. Cell Mol Life Sci 66:1-8. http://dx.doi.org/10.1007/s00018-008-8483-6.
2. Hodgson NC. 2005. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 89:1-4. http://dx.doi.org/10.1002/jso.20167.
3. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Penas PE, Nghiem P. 2008. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. JAmAcad Dermatol 58:375-381. http://dx.doi.org/10.1016/j.jaad.2007.11.020.
4. Lemos B, Nghiem P. 2007. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 127:2100-2103. http://dx.doi.org/10.1038/sj.jid.5700925.
5. Schrama D, Ugurel S, Becker JC. 2012. Merkel cell carcinoma: recent insights and new treatment options. Curr Opin Oncol 24:141-149. http://dx.doi.org/10.1097/CCO.0b013e32834fc9fe.
6. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100. http://dx.doi.org/10.1126/science.1152586.
7. Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernandez-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y. 2009. Human Merkel cell polyomavirus infection. I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 125:1243-1249. http://dx.doi.org/10.1002/ijc.24510.
8. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. 2008. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 105:16272-16277. http://dx.doi.org/10.1073/pnas.0806526105.
9. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC. 2010. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 84:7064-7072. http://dx.doi.org/10.1128/JVI.02400-09.
10. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. 2011. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest 121:3623-3634. http://dx.doi.org/10.1172/JCI46323.
11. Shuda M, Chang Y, Moore PS. 2014. Merkel cell polyomavirus-positive Merkel cell carcinoma requires viral small T-antigen for cell proliferation. J Invest Dermatol 134:1479-1481. http://dx.doi.org/10.1038/jid.2013.483.
12. Angermeyer S, Hesbacher S, Becker JC, Schrama D, Houben R. 2013. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen. J Invest Dermatol 133:2059-2064. http://dx.doi.org/10.1038/jid.2013.82.
13. Stakaityte G, Wood JJ, Knight LM, Abdul-Sada H, Adzahar NS, Nwogu N, Macdonald A, Whitehouse A. 2014. Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus. Cancers 6:1267-1297. http://dx.doi.org/10.3390/cancers6031267.
14. Kwun HJ, Shuda M, Feng H, Camacho CJ, Moore PS, Chang Y. 2013. Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCF(Fbw7.). Cell Host Microbe 14:125-135. http://dx.doi.org/10.1016/j.chom.2013.06.008.
15. Griffiths DA, Abdul-Sada H, Knight LM, Jackson BR, Richards K, Prescott EL, Peach AH, Blair GE, Macdonald A, Whitehouse A. 2013. Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling. J Virol 87:13853-13867. http://dx.doi.org/10.1128/JVI.02159-13.
16. Miller NJ, Bhatia S, Parvathaneni U, Iyer JG, Nghiem P. 2013. Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma. Curr Treat Options Oncol 14:249-263. http://dx.doi.org/10.1007/s11864-013-0225-9.
17. Gueron G, De Siervi A, Vazquez E. 2011. Key questions in metastasis: new insights in molecular pathways and therapeutic implications. Curr Pharm Biotechnol 12:1867-1880. http://dx.doi.org/10.2174/138920111798376996.
18. Chambers AF, Groom AC, MacDonald IC. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572. http://dx.doi.org/10.1038/nrc865.
19. Mehlen P, Puisieux A. 2006. Metastasis: a question of life or death. Nat Rev Cancer 6:449-458. http://dx.doi.org/10.1038/nrc1886.
20. Olson MF, Sahai E. 2009. The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis 26:273-287. http://dx.doi.org/10.1007/s10585-008-9174-2.
21. Kaverina I, Straube A. 2011. Regulation of cell migration by dynamic microtubules. Semin Cell Dev Biol 22:968-974. http://dx.doi.org/10.1016/j.semcdb.2011.09.017.
22. Etienne-Manneville S. 2013. Microtubules in cell migration. Annu Rev Cell Dev Biol 29:471-499. http://dx.doi.org/10.1146/annurev-cellbio-101011-155711.
23. de Forges H, Bouissou A, Perez F. 2012. Interplay between microtubule dynamics and intracellular organization. Int J Biochem Cell Biol 44:266-274. http://dx.doi.org/10.1016/j.biocel.2011.11.009.
24. Stehbens S, Wittmann T. 2012. Targeting and transport: how microtubules control focal adhesion dynamics. J Cell Biol 198:481-489. http://dx.doi.org/10.1083/jcb.201206050.
25. Ross JL, Ali MY, Warshaw DM. 2008. Cargo transport: molecular motors navigate a complex cytoskeleton. Curr Opin Cell Biol 20:41-47. http://dx.doi.org/10.1016/j.ceb.2007.11.006.
26. Gatlin JC, Bloom K. 2010. Microtubule motors in eukaryotic spindle assembly and maintenance. Semin Cell Dev Biol 21:248-254. http://dx.doi.org/10.1016/j.semcdb.2010.01.015.
27. Valiron O, Caudron N, Job D. 2001. Microtubule dynamics. Cell Mol Life Sci 58:2069-2084. http://dx.doi.org/10.1007/PL00000837.
28. Gardner MK, Zanic M, Howard J. 2013. Microtubule catastrophe and rescue. Curr Opin Cell Biol 25:14-22. http://dx.doi.org/10.1016/j.ceb.2012.09.006.
29. Olmsted JB. 1986. Microtubule-associated proteins. Annu Rev Cell Biol 2:421-457. http://dx.doi.org/10.1146/annurev.cb.02.110186.002225.
30. Belletti B, Baldassarre G. 2011. Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets 15: 1249-1266. http://dx.doi.org/10.1517/14728222.2011.620951.
31. Gavet O, Ozon S, Manceau V, Lawler S, Curmi P, Sobel A. 1998. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J Cell Sci 111:3333-3346.
32. Belmont LD, Mitchison TJ. 1996. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84:623-631. http://dx.doi.org/10.1016/S0092-8674(00)81037-5.
33. Steinmetz MO. 2007. Structure and thermodynamics of the tubulinstathmin interaction. J Struct Biol 158:137-147. http://dx.doi.org/10.1016/j.jsb.2006.07.018.
34. Manna T, Thrower DA, Honnappa S, Steinmetz MO, Wilson L. 2009. Regulation of microtubule dynamic instability in vitro by differentially phosphorylated stathmin. J Biol Chem 284:15640-15649. http://dx.doi.org/10.1074/jbc.M900343200.
35. Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K, Canzonieri V, D'Andrea S, Zucchetto A, Friedl P, Colombatti A, Baldassarre G. 2008. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 19:2003-2013. http://dx.doi.org/10.1091/mbc.E07-09-0894.
36. Nemunaitis J. 2012. Stathmin 1: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets 16:631-634. http://dx.doi.org/10.1517/14728222.2012.696101.
37. Rana S, Maples PB, Senzer N, Nemunaitis J. 2008. Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther 8:1461-1470. http://dx.doi.org/10.1586/14737140.8.9.1461.
38. Chen J, Abi-Daoud M, Wang A, Yang X, Zhang X, Feilotter HE, Tron VA. 2013. Stathmin 1 is a potential novel oncogene in melanoma. Oncogene 32:1330-1337. http://dx.doi.org/10.1038/onc.2012.141.
39. Tan HT, Wu W, Ng YZ, Zhang X, Yan B, Ong CW, Tan S, Salto-Tellez M, Hooi SC, Chung MC. 2012. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker. J Proteome Res 11:1433-1445. http://dx.doi.org/10.1021/pr2010956.
40. Byrne FL, Yang L, Phillips PA, Hansford LM, Fletcher JI, Ormandy CJ, McCarroll JA, Kavallaris M. 2014. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model. Oncogene 33:882-890. http://dx.doi.org/10.1038/onc.2013.11.
41. Li N, Jiang P, Du W, Wu Z, Li C, Qiao M, Yang X, Wu M. 2011. Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules. Proc Natl Acad Sci USA 108:12851-12856. http://dx.doi.org/10.1073/pnas.1017372108.
42. Misek DE, Chang CL, Kuick R, Hinderer R, Giordano TJ, Beer DG, Hanash SM. 2002. Transforming properties of a Q18→E mutation of the microtubule regulator Op18. Cancer Cell 2:217-228. http://dx.doi.org/10.1016/S1535-6108(02)00124-1.
43. Hall KT, Giles MS, Calderwood MA, Goodwin DJ, Matthews DA, Whitehouse A. 2002. The herpesvirus saimiri open reading frame 73 gene product interacts with the cellular protein p32. J Virol 76:11612-11622. http://dx.doi.org/10.1128/JVI.76.22.11612-11622.2002.
44. Hall KT, Stevenson AJ, Goodwin DJ, Gibson PC, Markham AF, Whitehouse A. 1999. The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein. J Virol 73:9756-7337.
45. Goodwin DJ, Walters MS, Smith PG, Thurau M, Fickenscher H, Whitehouse A. 2001. Herpesvirus saimiri open reading frame 50 (Rta) protein reactivates the lytic replication cycle in a persistently infected A549 cell line. J Virol 75:4008-4013. http://dx.doi.org/10.1128/JVI.75.8.4008-4013.2001.
46. Whitehouse A, Stevenson A, Cooper M, Meredith D. 1997. Identification of a cis-acting element within the herpesvirus saimiriORF6 promoter that is responsive to the HVS.R transactivator. J Gen Virol 78:1411-2658.
47. Ong SE, Mann M. 2006. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc 1:2650-2660. http://dx.doi.org/10.1038/nprot.2006.427.
48. Munday DC, Surtees R, Emmott E, Dove BK, Digard P, Barr JN, Whitehouse A, Matthews D, Hiscox JA. 2012. Using SILAC and quantitative proteomics to investigate the interactions between viral and host proteomes. Proteomics 12:666-672. http://dx.doi.org/10.1002/pmic.201100488.
49. Cox J, Mann M. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367-1372. http://dx.doi.org/10.1038/nbt.1511.
50. Hiscox JA, Whitehouse A, Matthews DA. 2010. Nucleolar proteomics and viral infection. Proteomics 10:4077-4086. http://dx.doi.org/10.1002/pmic.201000251.
51. Huang Da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. http://dx.doi.org/10.1038/nprot.2008.211.
52. Boyne JR, Jackson BR, Taylor A, Macnab SA, Whitehouse A. 2010. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs. EMBO J 29:1851-1864. http://dx.doi.org/10.1038/emboj.2010.77.
53. Jackson BR, Boyne JR, Noerenberg M, Taylor A, Hautbergue GM, Walsh MJ, Wheat R, Blackbourn DJ, Wilson SA, Whitehouse A. 2011. An interaction between KSHV ORF57 and UIF provides mRNA-adaptor redundancy in herpesvirus intronless mRNA export. PLoS Pathog 7:e1002138. http://dx.doi.org/10.1371/journal.ppat.1002138.
54. Emmott E, Dove BK, Howell G, Chappell LA, Reed ML, Boyne JR, You JH, Brooks G, Whitehouse A, Hiscox JA. 2008. Viral nucleolar localisation signals determine dynamic trafficking within the nucleolus. Virology 380:191-202. http://dx.doi.org/10.1016/j.virol.2008.05.032.
55. Wheat R, Roberts C, Waterboer T, Steele J, Marsden J, Steven NM, Blackbourn DJ. 2014. Inflammatory cell distribution in primary Merkel cell carcinoma. Cancers 6:1047-1064. http://dx.doi.org/10.3390/cancers6021047.
56. Jackson BR, Noerenberg M, Whitehouse A. 2014. A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells. PLoS Pathog 10:e1004098. http://dx.doi.org/10.1371/journal.ppat.1004098.
57. Hong Y, Macnab S, Lambert LA, Turner AJ, Whitehouse A, Usmani BA. 2011. Herpesvirus saimiri-based endothelin-converting enzyme-1 shRNA expression decreases prostate cancer cell invasion and migration. Int J Cancer 129:586-598. http://dx.doi.org/10.1002/ijc.25719.
58. Goodwin DJ, Hall KT, Giles MS, Calderwood MA, Markham AF, Whitehouse A. 2000. The carboxy terminus of the herpesvirus saimiri ORF 57 gene contains domains that are required for transactivation and transrepression. J Gen Virol 81:2253-2658.
59. Gurland G, Gundersen GG. 1993. Protein phosphatase inhibitors induce the selective breakdown of stable microtubules in fibroblasts and epithelial cells. Proc Natl Acad Sci USA 90:8827-8831. http://dx.doi.org/10.1073/pnas.90.19.8827.
60. Piperno G, LeDizet M, Chang XJ. 1987. Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 104:289-302. http://dx.doi.org/10.1083/jcb.104.2.289.
61. Cortes J, Vidal M. 2012. Beyond taxanes: the next generation of microtubule-targeting agents. Breast Cancer Res Treat 133:821-830. http://dx.doi.org/10.1007/s10549-011-1875-6.
62. Hulkower KI, Herber RL. 2011. Cell migration and invasion assays as tools for drug discovery. Pharmaceutics 3:107-124. http://dx.doi.org/10.3390/pharmaceutics3010107.
63. Myles T, Schmidt K, Evans DR, Cron P, Hemmings BA. 2001. Activesite mutations impairing the catalytic function of the catalytic subunit of human protein phosphatase 2A permit baculovirus-mediated overexpression in insect cells. Biochem J 357:225-232. http://dx.doi.org/10.1042/0264-6021:3570225.
64. Zhou G, Mihindukulasuriya KA, MacCorkle-Chosnek RA, Van Hooser A, Hu MC, Brinkley BR, Tan TH. 2002. Protein phosphatase 4 is involved in tumor necrosis factor-alpha-induced activation of c-Jun N-terminal kinase. J Biol Chem 277:6391-6398. http://dx.doi.org/10.1074/jbc.M107014200.
65. Evans DR, Hemmings BA. 2000. Mutation of the C-terminal leucine residue of PP2Ac inhibits PR55/B subunit binding and confers supersensitivity to microtubule destabilization in Saccharomyces cerevisiae. Mol Gen Genet 264:425-432. http://dx.doi.org/10.1007/s004380000302.
66. Yasmeen A, Bismar TA, Kandouz M, Foulkes WD, Desprez P-Y, Al Moustafa A-E. 2007. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle 6:2038-2042. http://dx.doi.org/10.4161/cc.6.16.4555.
67. Kaul R, Murakami M, Choudhuri T, Robertson ES. 2007. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J Virol 81:10352-10361. http://dx.doi.org/10.1128/JVI.00886-07.
68. Nunbhakdi-Craig V, Craig L, Machleidt T, Sontag E. 2003. Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J Virol 77:2807-2818. http://dx.doi.org/10.1128/JVI.77.5.2807-2818.2003.
69. Sze KM, Chu GK, Lee JM, Ng IO. 2013. C-terminal truncated hepatitis B virus X protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 57:131-139. http://dx.doi.org/10.1002/hep.25979.
70. Howell B, Larsson N, Gullberg M, Cassimeris L. 1999. Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin. Mol Biol Cell 10:105-118. http://dx.doi.org/10.1091/mbc.10.1.105.
71. Ng DC, Lin BH, Lim CP, Huang G, Zhang T, Poli V, Cao X. 2006. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 172:245-257. http://dx.doi.org/10.1083/jcb.200503021.
72. Wittmann T, Bokoch GM, Waterman-Storer CM. 2004. Regulation of microtubule destabilizing activity of Op18/stathmin downstream of Rac1. J Biol Chem 279:6196-6203. http://dx.doi.org/10.1074/jbc.M307261200.
73. Friedl P, Brocker EB. 2000. The biology of cell locomotion within threedimensional extracellular matrix. Cell Mol Life Sci 57:41-64. http://dx.doi.org/10.1007/s000180050498.
74. Sahai E, Marshall CJ. 2003. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5:711-719. http://dx.doi.org/10.1038/ncb1019.
75. Mistry SJ, Li HC, Atweh GF. 1998. Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin. Biochem J 334:23-29.
76. Toyo-oka K, Mori D, Yano Y, Shiota M, Iwao H, Goto H, Inagaki M, Hiraiwa N, Muramatsu M, Wynshaw-Boris A, Yoshiki A, Hirotsune S. 2008. Protein phosphatase 4 catalytic subunit regulates Cdk1 activity and microtubule organization via NDEL1 dephosphorylation. J Cell Biol 180: 1133-1147. http://dx.doi.org/10.1083/jcb.200705148.
77. Arora R, Shuda M, Guastafierro A, Feng H, Toptan T, Tolstov Y, Normolle D, Vollmer LL, Vogt A, Domling A, Brodsky JL, Chang Y, Moore PS. 2012. Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med 4:133ra56. http://dx.doi.org/10.1126/scitranslmed.3003713.